Hitting where it hurts: Exploiting cancer cell 'addiction' may lead to new therapies
Monday, June 1, 2009 - 11:35
in Biology & Nature
A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research, published by Cell Press in the June 2nd issue of the journal Cancer Cell, identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.
Read the whole article on Physorg
More from Physorg
Related
- Hitting where it hurts: Exploiting cancer cell 'addiction' may lead to new therapiesMon, 1 Jun 2009, 12:30:56 EDT
- Viral mimic induces melanoma cells to digest themselvesMon, 3 Aug 2009, 13:23:24 EDT
- Gene plays dual role in breast cancers with poor prognosisMon, 5 Jan 2009, 12:29:46 EST
- Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1Thu, 29 Jan 2009, 15:45:54 EST
- Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cellsWed, 21 Oct 2009, 13:30:15 EDT